Clinical Issues in Type 1 and Type 2 Diabetes


Pharmacodynamic Effects of Single Doses of the Glucagon Receptor Antagonist LGD-6972 in Healthy Subjects and Subjects with Type 2 Diabetes Mellitus (T2DM)
Eric G. Vajda, Diane J. Plotkin, Douglas K. Logan, Yong-Xi Li, David G Orloff, J. D. Pipkin, Lin Zhi and Keith B. Marschke


Impact of Subcutaneous Detemir Insulin on Rebound Hyperglycemia in Hospitalized Patients with Diabetes Transitioning from a Continuous Intravenous Insulin Infusion
Cecilia C. Low Wang, Rebecca Sanagorski, R Matthew Hawkins, Joanna Gibbs, Kenneth Tompkins, Mark Bridenstine, Stacey Seggelke and Boris Draznin